首页 > 最新文献

European Neuropsychopharmacology最新文献

英文 中文
MULTI-ANCESTRY FINE-MAPPING REFINES BIPOLAR DISORDER RISK GENES 多基因精细图谱完善躁郁症风险基因
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.035
Maria Koromina , Kai Yuan , Sanan Venkatesh , Kevin S. O'Connell , Friederike David , Psychiatric Genomics Consortium Bipolar Disorder Working Group , Jonathan Coleman , Georgios Voloudakis , Panos Roussos , Niamh Mullins
Genome wide association studies (GWAS) have identified hundreds of loci contributing to bipolar disorder (BD) risk. However, translating genome-wide significant (GWS) loci into causal genes and mechanisms for BD is challenging due to linkage disequilibrium (LD) between risk variants, and incomplete understanding of the non-coding regulatory mechanisms in the brain. Recently, the Psychiatric Genomics Consortium Bipolar Disorder Working Group has performed GWAS meta-analyses of BD in cohorts of European (N cases = 131,969), East Asian (N cases = 5,969), African American (N cases = 7,076) and Latino (N cases = 13,022) ancestries, as well as a multi-ancestry meta-analysis (Total N = 158,036 cases, N= 2,796,499 controls) by including datasets with different ascertainment strategies. These analyses led to the identification of 298 GWS risk loci for BD, further emphasizing the need to identify the true causal variants and elucidate their biological mechanisms at the cellular level.
Here, we implemented SuSiEx, a statistical fine-mapping method leveraging differences in the LD architecture among different genetic ancestries, to prioritize likely causal SNPs, within these 298 GWS risk loci for BD. Then, we mapped these SNPs to their relevant gene(s), and investigated their likely functional consequences by aggregating multiple lines of evidence: (i) integration of variant annotation and brain cell-type epigenomic data (PLAC-seq data), (ii) implementation of Summary data-based Mendelian Randomization (SMR) to functionally interpret the likely causal SNPs in the context of brain bulk tissue quantitative trait loci (QTLs) (expression, splicing and methylation QTLs), and (iii) refining the cell-type specific context of likely causal SNPs via SMR, by leveraging a novel (unpublished) resource of brain single nuclei eQTLs.
Our comprehensive fine-mapping analysis prioritized 113 likely causal SNPs, from 298 GWS loci for BD using LD estimates from all 4 represented populations in the multi-ancestry GWAS. By integrating expression, splicing or methylation QTLs, preliminary results based on a previous BD GWAS indicated that the following genes, among others, are strongly implicated in BD: FURIN, FADS1, DCC, MED24, TTC12, SP4, POU6F2, TRANK1, and DDRD2. Additionally, our preliminary results showed that fine-mapped SNPs for BD can mediate their likely causal effect in specific brain cell-types, specifically inhibitory and excitatory neurons. Taken together, the abovementioned genes represent promising candidates for functional experiments to understand biological mechanisms and therapeutic potential. Finally, we demonstrated that fine-mapping effect sizes can improve performance and transferability of BD polygenic risk scores across ancestrally diverse populations, thus highlighting the potential clinical utility of fine-mapping.
全基因组关联研究(GWAS)发现了数百个导致躁狂症(BD)风险的基因位点。然而,由于风险变异之间的连锁不平衡(LD)以及对大脑中非编码调控机制的不完全了解,将全基因组重要(GWS)位点转化为双相情感障碍的因果基因和机制具有挑战性。最近,精神病基因组学联盟躁郁症工作组对欧洲人(病例数=131969)、东亚人(病例数=5969)、非洲裔美国人(病例数=7076)和拉丁裔美国人(病例数=13022)血统队列中的躁郁症进行了GWAS荟萃分析,并通过纳入不同确定策略的数据集进行了多队列荟萃分析(总病例数=158036,对照数=2796499)。通过这些分析,我们确定了298个BD的GWS风险位点,进一步强调了确定真正的致病变异并在细胞水平阐明其生物学机制的必要性。在这里,我们采用了SuSiEx--一种利用不同遗传祖先之间LD结构差异的统计精细映射方法,在这298个BD的GWS风险位点中优先选择可能的致病SNPs。然后,我们将这些 SNPs 映射到其相关基因上,并通过整合多种证据来研究其可能的功能性后果:(i)整合变异注释和脑细胞类型表观基因组数据(PLAC-seq 数据);(ii)实施基于摘要数据的孟德尔随机化(SMR),在脑大块组织定量性状位点(QTLs)(表达、剪接和甲基化 QTLs)的背景下从功能上解释可能的致病 SNPs;(iii)通过 SMR,利用新颖的(未发表的)脑单核 eQTLs 资源,完善可能的致病 SNPs 的细胞类型特定背景。我们的综合精细图谱分析从 298 个 GWS 位点中优先筛选出 113 个可能是 BD 病因的 SNPs,这些 SNPs 采用了多种群 GWAS 中所有 4 个代表性种群的 LD 估计值。通过整合表达、剪接或甲基化 QTLs,基于之前 BD GWAS 的初步结果显示,以下基因与 BD 密切相关:FURIN、FADS1、DCC、MED24、TTC12、SP4、POU6F2、TRANK1 和 DDRD2。此外,我们的初步研究结果表明,BD 的精细映射 SNPs 可在特定脑细胞类型(特别是抑制性和兴奋性神经元)中介导其可能的因果效应。综上所述,上述基因是有希望进行功能实验以了解生物学机制和治疗潜力的候选基因。最后,我们证明了精细图谱效应大小可以提高BD多基因风险评分在不同祖先人群中的表现和可转移性,从而突出了精细图谱的潜在临床实用性。
{"title":"MULTI-ANCESTRY FINE-MAPPING REFINES BIPOLAR DISORDER RISK GENES","authors":"Maria Koromina ,&nbsp;Kai Yuan ,&nbsp;Sanan Venkatesh ,&nbsp;Kevin S. O'Connell ,&nbsp;Friederike David ,&nbsp;Psychiatric Genomics Consortium Bipolar Disorder Working Group ,&nbsp;Jonathan Coleman ,&nbsp;Georgios Voloudakis ,&nbsp;Panos Roussos ,&nbsp;Niamh Mullins","doi":"10.1016/j.euroneuro.2024.08.035","DOIUrl":"10.1016/j.euroneuro.2024.08.035","url":null,"abstract":"<div><div>Genome wide association studies (GWAS) have identified hundreds of loci contributing to bipolar disorder (BD) risk. However, translating genome-wide significant (GWS) loci into causal genes and mechanisms for BD is challenging due to linkage disequilibrium (LD) between risk variants, and incomplete understanding of the non-coding regulatory mechanisms in the brain. Recently, the Psychiatric Genomics Consortium Bipolar Disorder Working Group has performed GWAS meta-analyses of BD in cohorts of European (N cases = 131,969), East Asian (N cases = 5,969), African American (N cases = 7,076) and Latino (N cases = 13,022) ancestries, as well as a multi-ancestry meta-analysis (Total N = 158,036 cases, N= 2,796,499 controls) by including datasets with different ascertainment strategies. These analyses led to the identification of 298 GWS risk loci for BD, further emphasizing the need to identify the true causal variants and elucidate their biological mechanisms at the cellular level.</div><div>Here, we implemented SuSiEx, a statistical fine-mapping method leveraging differences in the LD architecture among different genetic ancestries, to prioritize likely causal SNPs, within these 298 GWS risk loci for BD. Then, we mapped these SNPs to their relevant gene(s), and investigated their likely functional consequences by aggregating multiple lines of evidence: (i) integration of variant annotation and brain cell-type epigenomic data (PLAC-seq data), (ii) implementation of Summary data-based Mendelian Randomization (SMR) to functionally interpret the likely causal SNPs in the context of brain bulk tissue quantitative trait loci (QTLs) (expression, splicing and methylation QTLs), and (iii) refining the cell-type specific context of likely causal SNPs via SMR, by leveraging a novel (unpublished) resource of brain single nuclei eQTLs.</div><div>Our comprehensive fine-mapping analysis prioritized 113 likely causal SNPs, from 298 GWS loci for BD using LD estimates from all 4 represented populations in the multi-ancestry GWAS. By integrating expression, splicing or methylation QTLs, preliminary results based on a previous BD GWAS indicated that the following genes, among others, are strongly implicated in BD: FURIN, FADS1, DCC, MED24, TTC12, SP4, POU6F2, TRANK1, and DDRD2. Additionally, our preliminary results showed that fine-mapped SNPs for BD can mediate their likely causal effect in specific brain cell-types, specifically inhibitory and excitatory neurons. Taken together, the abovementioned genes represent promising candidates for functional experiments to understand biological mechanisms and therapeutic potential. Finally, we demonstrated that fine-mapping effect sizes can improve performance and transferability of BD polygenic risk scores across ancestrally diverse populations, thus highlighting the potential clinical utility of fine-mapping.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 11-12"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHAT IS THE IMPACT OF COMPOUND HETEROZYGOUS EVENTS INVOLVING DELETIONS AND SEQUENCE-LEVEL VARIANTS IN AUTISM? 涉及缺失和序列变异的复合杂合事件对自闭症有什么影响?
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.080
Worrawat Engchuan , Brett Trost , Marla Mendes de Aquino , David Mager , Mehdi Zarrei , Rulan Shaath , Rayssa de Melo Wanderley , Faraz Ali , Nickie Safarian , Alex Chan , Shania Wu , Stephen W. Scherer , Elemi Breetvelt , Jacob Vorstman
<div><div>The majority of human genes maintain normal biological function when they become haploid due to a genomic deletion. However, pathogenicity may still arise when the remaining allele is affected by additional functional variation. Here, we describe analytical strategies for examining a specific type of compound heterozygosity, namely the co-occurrence of a deletion and a sequence-level variant affecting the other allele, hereafter referred to as deletion compound heterozygosity (DelCH). We report preliminary results in using these strategies to assess DelCH in Autism Spectrum Disorder (ASD).</div><div>We analyzed whole-genome sequencing data from MSSNG, Simons Simplex Collection, and SPARK cohorts (collectively 11,636 autistic individuals and 22,962 family members).</div><div>We developed multiple analytical strategies to examine rare (event rate < 1%) DelCH:<ul><li><span>1)</span><span><div>The burden analysis uses conditional logistic regression for group-level comparisons of DelCH rates between a) probands and their deletion-transmitting parents, with inherited deletion as a random effect variable, or b) probands and their family members, with family ID as a random effect variable;</div></span></li><li><span>2)</span><span><div>The transmission disequilibrium test (TDT) compares the rates with which deletion-non-transmitting parents transmit sequence-level variants within genes affected by deletions to their autistic offspring. Association is indicated by transmission of non-synonymous variants at a rate higher than predicted by chance. This approach was repeated in unaffected siblings as an additional control analysis.</div></span></li></ul></div><div>Each strategy has different strengths and weaknesses. The first burden analysis (1a) achieves perfect matching of deleted sequence and unambiguous phasing of variants but is restricted to proband-parent pairs. The second burden analysis (1b) benefits from a larger sample size but cannot distinguish between de novo and inherited variation. In addition, unambiguous phasing is possible only for SNVs within deletion boundaries. In contrast, while the TDT (2) can include SNVs outside deletion boundaries, thereby increasing statistical power, de novo events are not analyzed.</div><div>Our preliminary findings show variability in results as a function of the analytical strategy. Findings from the burden analysis suggest a modest enrichment of DelCH in ASD which was inversely proportional to the variant frequency thresholds applied.</div><div>Given that the mechanism consists of two rare events at the same locus, on the population level the role of DelCH in ASD etiology is likely modest, requiring large samples sizes for sufficient statistical power. In addition to this “lightning striking twice”, data preparation is demanding, as every subject has unique deletion regions in which sequence-level variants on the other allele are tallied. Variant selection metrics include allele frequency thres
当基因组缺失导致单倍体时,大多数人类基因都能保持正常的生物功能。然而,当剩余等位基因受到额外功能变异的影响时,致病性仍然可能产生。在此,我们将介绍一种特定类型复合杂合性的分析策略,即缺失和影响另一个等位基因的序列级变异的共同发生,以下简称缺失复合杂合性(DelCH)。我们分析了来自 MSSNG、Simons Simplex Collection 和 SPARK 队列的全基因组测序数据(共有 11,636 名自闭症患者和 22,962 名家庭成员)。我们开发了多种分析策略来研究罕见(事件发生率为 1%)的 DelCH:1)负担分析使用条件逻辑回归对以下两种情况的 DelCH 发生率进行群体水平的比较:a)将遗传性缺失作为随机效应变量,比较受试者与其缺失传播父母之间的 DelCH 发生率;或 b)将家庭 ID 作为随机效应变量,比较受试者与其家庭成员之间的 DelCH 发生率;2)传播不平衡检验(TDT)比较缺失非传播父母将受缺失影响的基因内的序列水平变异传播给其自闭症后代的比率。如果非同义变异的传递率高于偶然预测的传递率,则表明存在关联。作为额外的对照分析,在未受影响的兄弟姐妹中重复了这一方法。第一种负荷分析(1a)实现了删除序列的完美匹配和变异体的明确分期,但仅限于原核父母配对。第二种负担分析(1b)受益于更大的样本量,但无法区分从头变异和遗传变异。此外,只有在缺失边界内的 SNV 才有可能进行明确的分期。与此相反,虽然 TDT(2)可以包括缺失边界以外的 SNV,从而提高统计能力,但却无法分析从新发生的事件。负担分析的结果表明,DelCH 在 ASD 中的富集程度不高,与应用的变异频率阈值成反比。鉴于其机制由同一位点上的两个罕见事件组成,在人群水平上,DelCH 在 ASD 病因学中的作用可能不大,需要大样本量才能获得足够的统计能力。除了 "雷击两次 "之外,数据准备工作也要求很高,因为每个受试者都有独特的缺失区域,其中另一个等位基因上的序列级变异需要统计。变异选择指标包括等位基因频率阈值、常染色体显性缺失性预测阈值以及与缺失边界相关的变异包含规则。我们的研究结果表明,改变其中任何一个指标都会影响研究结果,因此需要慎重考虑。了解 DelCH 的潜在作用可能有助于建立更全面的 ASD 相关遗传变异库。DelCH可以解释为什么个别ASD患者会出现遗传自非受影响父母的缺失。最后,在遗传分析中研究DelCH可能有助于发现隐性ASD基因,否则这些基因将无法被发现。
{"title":"WHAT IS THE IMPACT OF COMPOUND HETEROZYGOUS EVENTS INVOLVING DELETIONS AND SEQUENCE-LEVEL VARIANTS IN AUTISM?","authors":"Worrawat Engchuan ,&nbsp;Brett Trost ,&nbsp;Marla Mendes de Aquino ,&nbsp;David Mager ,&nbsp;Mehdi Zarrei ,&nbsp;Rulan Shaath ,&nbsp;Rayssa de Melo Wanderley ,&nbsp;Faraz Ali ,&nbsp;Nickie Safarian ,&nbsp;Alex Chan ,&nbsp;Shania Wu ,&nbsp;Stephen W. Scherer ,&nbsp;Elemi Breetvelt ,&nbsp;Jacob Vorstman","doi":"10.1016/j.euroneuro.2024.08.080","DOIUrl":"10.1016/j.euroneuro.2024.08.080","url":null,"abstract":"&lt;div&gt;&lt;div&gt;The majority of human genes maintain normal biological function when they become haploid due to a genomic deletion. However, pathogenicity may still arise when the remaining allele is affected by additional functional variation. Here, we describe analytical strategies for examining a specific type of compound heterozygosity, namely the co-occurrence of a deletion and a sequence-level variant affecting the other allele, hereafter referred to as deletion compound heterozygosity (DelCH). We report preliminary results in using these strategies to assess DelCH in Autism Spectrum Disorder (ASD).&lt;/div&gt;&lt;div&gt;We analyzed whole-genome sequencing data from MSSNG, Simons Simplex Collection, and SPARK cohorts (collectively 11,636 autistic individuals and 22,962 family members).&lt;/div&gt;&lt;div&gt;We developed multiple analytical strategies to examine rare (event rate &lt; 1%) DelCH:&lt;ul&gt;&lt;li&gt;&lt;span&gt;1)&lt;/span&gt;&lt;span&gt;&lt;div&gt;The burden analysis uses conditional logistic regression for group-level comparisons of DelCH rates between a) probands and their deletion-transmitting parents, with inherited deletion as a random effect variable, or b) probands and their family members, with family ID as a random effect variable;&lt;/div&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;2)&lt;/span&gt;&lt;span&gt;&lt;div&gt;The transmission disequilibrium test (TDT) compares the rates with which deletion-non-transmitting parents transmit sequence-level variants within genes affected by deletions to their autistic offspring. Association is indicated by transmission of non-synonymous variants at a rate higher than predicted by chance. This approach was repeated in unaffected siblings as an additional control analysis.&lt;/div&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div&gt;Each strategy has different strengths and weaknesses. The first burden analysis (1a) achieves perfect matching of deleted sequence and unambiguous phasing of variants but is restricted to proband-parent pairs. The second burden analysis (1b) benefits from a larger sample size but cannot distinguish between de novo and inherited variation. In addition, unambiguous phasing is possible only for SNVs within deletion boundaries. In contrast, while the TDT (2) can include SNVs outside deletion boundaries, thereby increasing statistical power, de novo events are not analyzed.&lt;/div&gt;&lt;div&gt;Our preliminary findings show variability in results as a function of the analytical strategy. Findings from the burden analysis suggest a modest enrichment of DelCH in ASD which was inversely proportional to the variant frequency thresholds applied.&lt;/div&gt;&lt;div&gt;Given that the mechanism consists of two rare events at the same locus, on the population level the role of DelCH in ASD etiology is likely modest, requiring large samples sizes for sufficient statistical power. In addition to this “lightning striking twice”, data preparation is demanding, as every subject has unique deletion regions in which sequence-level variants on the other allele are tallied. Variant selection metrics include allele frequency thres","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Page 32"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE POLYGENETIC ARCHITECTURE OF AUTISM 自闭症的多基因结构
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.045
Jing Zhang , Jakob Grove , Caitlin Carey , Jack Fu , F. Kyle Satterstrom , Susan Kuo , Ajay Nadig , Swapnil Awasthi , Kaitlin Samocha , Anders Børglum , Elise Robinson
Autism is highly heritable and has been associated with multiple classes of genetic variation. Common genetic variation contributes substantially to autism. Previously, with 18,381 autistic individuals and 27,969 non-autistic individuals, five genome-wide significant loci were identified. Now with 38,717 autistic individuals and 232,725 non-autistic individuals, we report an updated genome-wide association study (GWAS) of autism with 12 genome-wide significant loci. We observe a moderate genetic correlation (0.675, SE=0.0434) between Europe-based (Nautistic=22,643; Nnon-autistic=204,389) and United States-based (Nautistic =16,074; Nnon-autistic=28,346) autism cohorts, which contributes to the decline of the estimated single nucleotide polymorphism (SNP) heritability (from 0.118 (SE=0.010) to 0.068 (SE=0.003)). The genetic correlation between autism with intellectual disability (ID) (Nautistic=6,590; Nnon-autistic= 43,071; h2=0.062; SE=0.012) and autism without ID (Nautistic=23,173; Nnon-autistic= 204,679; h2=0.089; SE=0.005) is 0.658 (SE=0.086). In the United States family-based cohorts, the genetic correlation between autism with ID (Nfamily=3,993; h2=0.159; SE=0.033) and autism without ID (Nfamily=4,357; h2=0.171; SE=0.031) is 0.812 (SE=0.157). Autism without ID was positively genetically correlated with educational attainment (0.163; P=4.84 × 10-11) and intelligence (0.233; P=1.95 × 10-11). Autism with ID genetically correlated with neither educational attainment (0.036; P=0.409) nor intelligence (-0.072; P=0.235). As ID alone is negatively genetically correlated with intelligence, the lack of correlation between autism with ID and intelligence strongly suggests that autism with ID is genetically different from ID alone. This difference has implications for both research and clinical nosology. Rare and de novo variants contribute substantially to autism in some individuals. Through rare variant analyses, 72 genes have been associated with autism at a genome-wide significant level to date. While de novo protein truncating variants (PTVs) and copy number deletions have been associated with autism, we report preliminary findings that the burden of inherited PTVs and copy number deletions among autistic individuals was elevated compared to their non-autistic siblings (P=4.00 × 10-5). Integration of multiple genetic factors will help us better understand the etiology of autism.
自闭症具有高度遗传性,与多种基因变异有关。常见的遗传变异对自闭症有很大的影响。此前,我们在 18,381 名自闭症患者和 27,969 名非自闭症患者中发现了五个全基因组重要位点。现在,我们以 38,717 名自闭症患者和 232,725 名非自闭症患者为研究对象,报告了一项最新的自闭症全基因组关联研究(GWAS),其中发现了 12 个具有重要意义的全基因组位点。我们观察到自闭症欧洲队列(Nautistic=22,643;Nnon-autistic=204,389)和美国队列(Nautistic=16,074;Nnon-autistic=28,346)之间存在中等程度的遗传相关性(0.675,SE=0.0434),这导致估计的单核苷酸多态性(SNP)遗传率下降(从 0.118(SE=0.010)降至 0.068(SE=0.003))。有智力障碍的自闭症(Nautistic=6 590;Nnon-autistic=43 071;h2=0.062;SE=0.012)与无智力障碍的自闭症(Nautistic=23 173;Nnon-autistic=204 679;h2=0.089;SE=0.005)之间的遗传相关性为 0.658(SE=0.086)。在美国以家庭为基础的队列中,有 ID 的自闭症(Nfamily=3,993;h2=0.159;SE=0.033)与无 ID 的自闭症(Nfamily=4,357;h2=0.171;SE=0.031)之间的遗传相关性为 0.812(SE=0.157)。无智障自闭症与教育程度(0.163;P=4.84 × 10-11)和智力(0.233;P=1.95 × 10-11)呈正相关。带有智障的自闭症与教育程度(0.036;P=0.409)和智力(-0.072;P=0.235)均无遗传相关性。由于单纯的智障与智力在基因上呈负相关,自闭症伴智障与智力之间缺乏相关性强烈表明,自闭症伴智障在基因上与单纯的智障不同。这种差异对研究和临床命名都有影响。罕见变异和新变异对某些个体的自闭症有重大影响。通过罕见变异分析,迄今已有 72 个基因与自闭症有全基因组意义上的关联。虽然从头蛋白质截断变异(PTVs)和拷贝数缺失与自闭症有关,但我们报告的初步研究结果表明,与非自闭症患者的兄弟姐妹相比,自闭症患者的遗传PTVs和拷贝数缺失的负担更高(P=4.00 × 10-5)。整合多种遗传因素将有助于我们更好地了解自闭症的病因。
{"title":"THE POLYGENETIC ARCHITECTURE OF AUTISM","authors":"Jing Zhang ,&nbsp;Jakob Grove ,&nbsp;Caitlin Carey ,&nbsp;Jack Fu ,&nbsp;F. Kyle Satterstrom ,&nbsp;Susan Kuo ,&nbsp;Ajay Nadig ,&nbsp;Swapnil Awasthi ,&nbsp;Kaitlin Samocha ,&nbsp;Anders Børglum ,&nbsp;Elise Robinson","doi":"10.1016/j.euroneuro.2024.08.045","DOIUrl":"10.1016/j.euroneuro.2024.08.045","url":null,"abstract":"<div><div>Autism is highly heritable and has been associated with multiple classes of genetic variation. Common genetic variation contributes substantially to autism. Previously, with 18,381 autistic individuals and 27,969 non-autistic individuals, five genome-wide significant loci were identified. Now with 38,717 autistic individuals and 232,725 non-autistic individuals, we report an updated genome-wide association study (GWAS) of autism with 12 genome-wide significant loci. We observe a moderate genetic correlation (0.675, SE=0.0434) between Europe-based (Nautistic=22,643; Nnon-autistic=204,389) and United States-based (Nautistic =16,074; Nnon-autistic=28,346) autism cohorts, which contributes to the decline of the estimated single nucleotide polymorphism (SNP) heritability (from 0.118 (SE=0.010) to 0.068 (SE=0.003)). The genetic correlation between autism with intellectual disability (ID) (Nautistic=6,590; Nnon-autistic= 43,071; h2=0.062; SE=0.012) and autism without ID (Nautistic=23,173; Nnon-autistic= 204,679; h2=0.089; SE=0.005) is 0.658 (SE=0.086). In the United States family-based cohorts, the genetic correlation between autism with ID (Nfamily=3,993; h2=0.159; SE=0.033) and autism without ID (Nfamily=4,357; h2=0.171; SE=0.031) is 0.812 (SE=0.157). Autism without ID was positively genetically correlated with educational attainment (0.163; P=4.84 × 10-11) and intelligence (0.233; P=1.95 × 10-11). Autism with ID genetically correlated with neither educational attainment (0.036; P=0.409) nor intelligence (-0.072; P=0.235). As ID alone is negatively genetically correlated with intelligence, the lack of correlation between autism with ID and intelligence strongly suggests that autism with ID is genetically different from ID alone. This difference has implications for both research and clinical nosology. Rare and de novo variants contribute substantially to autism in some individuals. Through rare variant analyses, 72 genes have been associated with autism at a genome-wide significant level to date. While de novo protein truncating variants (PTVs) and copy number deletions have been associated with autism, we report preliminary findings that the burden of inherited PTVs and copy number deletions among autistic individuals was elevated compared to their non-autistic siblings (P=4.00 × 10-5). Integration of multiple genetic factors will help us better understand the etiology of autism.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Page 16"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UPDATE FROM THE “PEDIGREE-BASED WHOLE GENOME SEQUENCING OF AFFECTIVE AND PSYCHOTIC DISORDERS" CONSORTIUM 基于谱系的情感障碍和精神障碍全基因组测序 "的最新进展联合会
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.082
{"title":"UPDATE FROM THE “PEDIGREE-BASED WHOLE GENOME SEQUENCING OF AFFECTIVE AND PSYCHOTIC DISORDERS\" CONSORTIUM","authors":"","doi":"10.1016/j.euroneuro.2024.08.082","DOIUrl":"10.1016/j.euroneuro.2024.08.082","url":null,"abstract":"","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Page 33"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EXPLORING MENTAL HEALTH STIGMA IN THE CONTEXT OF PSYCHIATRIC GENETICS: INSIGHTS FROM THE ISPG STIGMA REDUCTION SIG SURVEY 从精神病遗传学的角度探讨心理健康污名化问题:从国际精神病学协会减少耻辱感 SIG 调查中获得的启示
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.061
Elleke Tissink , Anaïs Thijssen , Janneke Zinkstok , Mandy Johnstone , Reeteka Sud , Jehannine Austin (J9) , Julia Sealock , Sarah E. Medland , Anna Docherty , Rada Veeneman
Mental health stigma takes many forms and remains a significant barrier to seeking help and achieving equitable conduct in the work environment. This may be particularly relevant within psychiatric genetics, where researchers, clinicians, and individuals with lived experience converge. Characterizing the nature, prevalence and impact of mental health stigma within the psychiatric genetics community will be an important step toward developing strategies to mitigate its effects and promote inclusivity. The ISPG Stigma Reduction Special Interest Group (SIG) aims to explore ISPG members' views and experiences regarding mental health stigma, with the goal of understanding areas in which the SIG might affect change.
The Stigma Reduction SIG developed a survey to capture ISPG members' experiences and perceptions of stigma related to mental health conditions, as well as their advice on how to address it. To assess stigma in the personal environment, we used a question from the Attribution Questionnaire (ref). For the remaining questions, we developed novel items, as there were no suitable validated questionnaires available to address the specific topics relevant to the psychiatric genetics community. The survey was constructed using Qualtrics software, with participants' anonymity ensured. We received ethical approval from the QIMR Berghofer Medical Research Institute. The survey was distributed electronically to ISPG members, including researchers, clinicians, and individuals with lived experience with mental health conditions.
During this talk, the (preliminary) results of the survey data will be presented.
The ISPG Stigma Reduction SIG plans to use the survey insights to develop targeted action points aimed at fostering a more inclusive environment. By sharing these findings at the World Congress of Psychiatric Genetics 2024, we hope to initiate a broader conversation on stigma reduction and inspire collaborative efforts to eliminate prejudice and discrimination against people with mental health conditions, including those working in the psychiatric genetics field.
心理健康污名有多种形式,仍然是寻求帮助和在工作环境中实现平等行为的重大障碍。在研究人员、临床医生和有生活经验的个人汇聚一堂的精神病遗传学中,这一点可能尤为重要。了解精神疾病遗传学界心理健康污名化的性质、普遍程度和影响,将是制定战略以减轻其影响并促进包容性的重要一步。ISPG 减少污名化特别兴趣小组(SIG)旨在探索 ISPG 成员对心理健康污名化的看法和经验,目的是了解 SIG 可能会影响变革的领域。减少污名化特别兴趣小组制定了一项调查,以收集 ISPG 成员对心理健康状况相关污名化的经验和看法,以及他们对如何解决这一问题的建议。为了评估个人环境中的成见,我们使用了归因问卷中的一个问题(参考)。至于其他问题,我们则开发了新的项目,因为目前还没有合适的有效问卷来解决与精神疾病遗传学群体相关的具体问题。调查使用 Qualtrics 软件制作,确保参与者的匿名性。我们获得了 QIMR Berghofer 医学研究所的伦理批准。该调查以电子方式分发给 ISPG 成员,包括研究人员、临床医生和有心理健康问题生活经验的个人。在本次演讲中,我们将介绍调查数据的(初步)结果。ISPG 减少污名化小组计划利用调查结论制定有针对性的行动要点,以营造更具包容性的环境。我们希望通过在2024年世界精神病遗传学大会上分享这些调查结果,发起一场更广泛的关于减少污名化的对话,并激励大家共同努力,消除对精神疾病患者的偏见和歧视,包括对精神病遗传学领域工作者的偏见和歧视。
{"title":"EXPLORING MENTAL HEALTH STIGMA IN THE CONTEXT OF PSYCHIATRIC GENETICS: INSIGHTS FROM THE ISPG STIGMA REDUCTION SIG SURVEY","authors":"Elleke Tissink ,&nbsp;Anaïs Thijssen ,&nbsp;Janneke Zinkstok ,&nbsp;Mandy Johnstone ,&nbsp;Reeteka Sud ,&nbsp;Jehannine Austin (J9) ,&nbsp;Julia Sealock ,&nbsp;Sarah E. Medland ,&nbsp;Anna Docherty ,&nbsp;Rada Veeneman","doi":"10.1016/j.euroneuro.2024.08.061","DOIUrl":"10.1016/j.euroneuro.2024.08.061","url":null,"abstract":"<div><div>Mental health stigma takes many forms and remains a significant barrier to seeking help and achieving equitable conduct in the work environment. This may be particularly relevant within psychiatric genetics, where researchers, clinicians, and individuals with lived experience converge. Characterizing the nature, prevalence and impact of mental health stigma within the psychiatric genetics community will be an important step toward developing strategies to mitigate its effects and promote inclusivity. The ISPG Stigma Reduction Special Interest Group (SIG) aims to explore ISPG members' views and experiences regarding mental health stigma, with the goal of understanding areas in which the SIG might affect change.</div><div>The Stigma Reduction SIG developed a survey to capture ISPG members' experiences and perceptions of stigma related to mental health conditions, as well as their advice on how to address it. To assess stigma in the personal environment, we used a question from the Attribution Questionnaire (ref). For the remaining questions, we developed novel items, as there were no suitable validated questionnaires available to address the specific topics relevant to the psychiatric genetics community. The survey was constructed using Qualtrics software, with participants' anonymity ensured. We received ethical approval from the QIMR Berghofer Medical Research Institute. The survey was distributed electronically to ISPG members, including researchers, clinicians, and individuals with lived experience with mental health conditions.</div><div>During this talk, the (preliminary) results of the survey data will be presented.</div><div>The ISPG Stigma Reduction SIG plans to use the survey insights to develop targeted action points aimed at fostering a more inclusive environment. By sharing these findings at the World Congress of Psychiatric Genetics 2024, we hope to initiate a broader conversation on stigma reduction and inspire collaborative efforts to eliminate prejudice and discrimination against people with mental health conditions, including those working in the psychiatric genetics field.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Page 23"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POST-GWAS FOR PTSD: FROM RISK LOCI TO BIOLOGICAL MEANING PTSD 的后 GWAS:从风险定位到生物学意义
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.013
Caroline Nievergelt (Chair) , Linnet Ongeri (Co-chair) , Joel Gelernter (Discussant)
<div><div>Posttraumatic stress disorder (PTSD) is a commonly occurring mental health consequence of exposure to extreme, often life-threatening events such as combat, sexual assault, natural disasters, and serious accidents. PTSD is frequently associated with other mental health disorders such as major depression and increased risk for suicide.</div><div>The Psychiatric Genomics Consortium PTSD (PGC-PTSD) workgroup has recently published the largest PTSD GWAS to date (Data Freeze 3), including over 90 different cohorts with over 1.25 million global participants and over 140,000 PTSD cases. With Data Freeze 3, PGC-PTSD has reached, for the first-time, adequate power to detect robust and replicable genomic signals for PTSD and has identified 95 PTSD loci across different ancestries.</div><div>Applying convergent multi-omic approaches, we tentatively identified potential causal genes, broadly classified as neurotransmitter and ion channel synaptic modulators, developmental, axon guidance, and transcription factors, synaptic structure and function genes, and endocrine or immune regulators. Additional top genes influence stress, immune, fear, and threat-related processes, previously hypothesized to underlie PTSD neurobiology.</div><div>This symposium from leading members of our working group will summarize the most recent advances in PTSD genetics and present a variety of avenues to follow-up on PTSD risk loci, with the goal to increase our understanding of the biological bases of risk for PTSD, its delineation from co-morbid disorders such as MDD, and optimize transferability of results across diverse ancestries.</div><div>Dr. Adam Maihofer (University of California San Diego) will start off the symposium by presenting two complementary methods leveraging comorbidity information to refine PTSD associations and dissect genetic risk with the goal to detect risk genes specific to PTSD.</div><div>Dr. Nikolaos Daskalakis (Harvard Medical School/ McLean Hospital) will follow-up on GWAS top loci with multi-omic studies of postmortem brains of PTSD and MDD patients, showing that fine-mapping of PTSD and MDD genome-wide association study results reveals limited overlap between risk and disease processes at the gene and pathway level.</div><div>Alice Braun (PhD candidate, Charité – Universitätsmedizin Berlin) will explore the immunogenetic basis of PTSD by focusing on the major histocompatibility complex (MHC), a complex region on chromosome 6 that harbors numerous genetic variants such as human leukocyte antigen (HLA) alleles that are crucial for immune function and has been identified as a risk locus for PTSD.</div><div>Finally, Dr. Marcos Santoro (Universidade Federal de São Paulo) will describe our efforts in the PGC-PSTD Ancestry Working Group on improving the inclusion of admixed individuals in PGC-PTSD, which currently include more than 50,000 African American and 13,000 Latin American individuals, with different and complex patterns of admixture accord
创伤后应激障碍(PTSD)是一种常见的精神疾病,是由于遭遇极端事件(通常是危及生命的事件,如战斗、性侵犯、自然灾害和严重事故)而导致的。精神病基因组学联合会创伤后应激障碍(PGC-PTSD)工作组最近发布了迄今为止最大的创伤后应激障碍基因组学研究(Data Freeze 3),其中包括 90 多个不同的队列,全球参与者超过 125 万人,创伤后应激障碍病例超过 14 万例。通过数据冻结 3,PGC-PTSD 首次达到了检测创伤后应激障碍强大且可复制的基因组信号的足够能力,并在不同的祖先中发现了 95 个创伤后应激障碍基因位点。"应用趋同的多基因组方法,我们初步确定了潜在的因果基因,大致分为神经递质和离子通道突触调节因子、发育、轴突导向和转录因子、突触结构和功能基因以及内分泌或免疫调节剂。我们工作小组的主要成员将在本次研讨会上总结创伤后应激障碍遗传学的最新进展,并介绍跟踪创伤后应激障碍风险基因位点的各种途径,目的是提高我们对创伤后应激障碍风险生物学基础的认识,将其与 MDD 等共病疾病区分开来,并优化不同祖先之间结果的可转移性。Adam Maihofer 博士(加利福尼亚大学圣迭戈分校)将在研讨会上首先介绍两种互补方法,即利用合并症信息来完善创伤后应激障碍的关联,并分析遗传风险,以检测创伤后应激障碍的特异性风险基因。Nikolaos Daskalakis 博士(哈佛大学医学院/麦克莱恩医院)将通过对创伤后应激障碍和抑郁症患者死后大脑的多组学研究来跟进 GWAS 的顶级位点,表明创伤后应激障碍和抑郁症全基因组关联研究结果的精细图谱显示,风险与疾病过程在基因和通路水平上的重叠有限。爱丽丝-布劳恩(Alice Braun,柏林夏里特大学博士生)将重点研究主要组织相容性复合体(MHC),从而探索创伤后应激障碍的免疫遗传学基础。MHC是第6号染色体上的一个复杂区域,蕴藏着大量遗传变异,如对免疫功能至关重要的人类白细胞抗原(HLA)等位基因,并已被确定为创伤后应激障碍的风险位点。最后,Marcos Santoro博士(圣保罗联邦大学)将介绍我们在PGC-PSTD祖先工作组中为改进将混血个体纳入PGC-PTSD所做的努力,目前PGC-PTSD中包括50,000多名非洲裔美国人和13,000多名拉丁美洲人,他们的混血模式因采集地区不同而不同且复杂。在这 4 个报告之后,Joel Gelernter 博士(耶鲁大学医学院)将主持讨论,总结和整合研究结果,并重点讨论联盟的下一步工作,即从发现创伤后应激障碍风险基因位点到生物学意义以及创伤和应激相关疾病发病机制的剖析。
{"title":"POST-GWAS FOR PTSD: FROM RISK LOCI TO BIOLOGICAL MEANING","authors":"Caroline Nievergelt (Chair) ,&nbsp;Linnet Ongeri (Co-chair) ,&nbsp;Joel Gelernter (Discussant)","doi":"10.1016/j.euroneuro.2024.08.013","DOIUrl":"10.1016/j.euroneuro.2024.08.013","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Posttraumatic stress disorder (PTSD) is a commonly occurring mental health consequence of exposure to extreme, often life-threatening events such as combat, sexual assault, natural disasters, and serious accidents. PTSD is frequently associated with other mental health disorders such as major depression and increased risk for suicide.&lt;/div&gt;&lt;div&gt;The Psychiatric Genomics Consortium PTSD (PGC-PTSD) workgroup has recently published the largest PTSD GWAS to date (Data Freeze 3), including over 90 different cohorts with over 1.25 million global participants and over 140,000 PTSD cases. With Data Freeze 3, PGC-PTSD has reached, for the first-time, adequate power to detect robust and replicable genomic signals for PTSD and has identified 95 PTSD loci across different ancestries.&lt;/div&gt;&lt;div&gt;Applying convergent multi-omic approaches, we tentatively identified potential causal genes, broadly classified as neurotransmitter and ion channel synaptic modulators, developmental, axon guidance, and transcription factors, synaptic structure and function genes, and endocrine or immune regulators. Additional top genes influence stress, immune, fear, and threat-related processes, previously hypothesized to underlie PTSD neurobiology.&lt;/div&gt;&lt;div&gt;This symposium from leading members of our working group will summarize the most recent advances in PTSD genetics and present a variety of avenues to follow-up on PTSD risk loci, with the goal to increase our understanding of the biological bases of risk for PTSD, its delineation from co-morbid disorders such as MDD, and optimize transferability of results across diverse ancestries.&lt;/div&gt;&lt;div&gt;Dr. Adam Maihofer (University of California San Diego) will start off the symposium by presenting two complementary methods leveraging comorbidity information to refine PTSD associations and dissect genetic risk with the goal to detect risk genes specific to PTSD.&lt;/div&gt;&lt;div&gt;Dr. Nikolaos Daskalakis (Harvard Medical School/ McLean Hospital) will follow-up on GWAS top loci with multi-omic studies of postmortem brains of PTSD and MDD patients, showing that fine-mapping of PTSD and MDD genome-wide association study results reveals limited overlap between risk and disease processes at the gene and pathway level.&lt;/div&gt;&lt;div&gt;Alice Braun (PhD candidate, Charité – Universitätsmedizin Berlin) will explore the immunogenetic basis of PTSD by focusing on the major histocompatibility complex (MHC), a complex region on chromosome 6 that harbors numerous genetic variants such as human leukocyte antigen (HLA) alleles that are crucial for immune function and has been identified as a risk locus for PTSD.&lt;/div&gt;&lt;div&gt;Finally, Dr. Marcos Santoro (Universidade Federal de São Paulo) will describe our efforts in the PGC-PSTD Ancestry Working Group on improving the inclusion of admixed individuals in PGC-PTSD, which currently include more than 50,000 African American and 13,000 Latin American individuals, with different and complex patterns of admixture accord","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 2-3"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE PGC-PSTD ANCESTRY WORKING GROUP: IMPROVING THE INCLUSION OF ADMIXED INDIVIDUALS IN PSYCHIATRIC GWAS PGC-PSTD 血统工作组:将混血儿更好地纳入精神疾病全球监测系统
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.016
Marcos Santoro , Jessica Mauer , Adam Maihofer , Nirav Shah , Caroline Nievergelt , Elizabeth Atkinson
The latest PGC-PTSD GWAS achieved a considerable increase in the sample sizes of non-European populations, including more than 50,000 African American (AA) and 13,000 Latin American (LA) individuals. One of the difficulties in analyzing these samples is that they are usually very admixed, with different patterns of admixture according to the region they have been collected. The PGC-PTSD Ancestry working group is focused on developing new tools to allow proper inclusion of admixed individuals in GWAS and to facilitate the use of these tools for LMIC collaborators. Previously, we developed Tractor, a gene discovery tool for admixed populations that uses Local Ancestry Inference (LAI) to allow the well-calibrated inclusion of these individuals in GWAS studies. Currently, one of the primary efforts is to comprehensively test strategies for LAI to provide guidelines for parameter setting and reference panel composition. For this, we have simulated admixed individuals considering different patterns of admixture (AA-2 way and LA-3 way), demographic models, software settings, genomic data types, and reference panels. These simulations allow us to define best practice guidelines for researchers to use when analyzing diverse populations to produce the highest accuracy results across ancestries.
In our tests, we observe that Amerindigenous ancestry tracts suffer from notably reduced accuracy as compared to European and African tracts. When miscalls occur, LAI error rates are most frequently in the direction of calling European ancestry in true Amerindigenous sites than other error modes. Though our investigations are directly responsive to realistic admixed Latin American cohort compositions, the trends we characterize are broadly useful to inform best practice for local ancestry inference across diverse admixed populations. In parallel with this initiative of improving LAI analysis accuracy, our working group is developing a friendly pipeline for Tractor so other consortia can apply this approach for large sample sizes. As a future perspective, the PGC-PTSD ancestry working group will also work on the development of new tools for post GWAS approaches as polygenic scores.
最新的 PGC-PTSD 基因组研究大大增加了非欧洲人群的样本量,其中包括 50,000 多名非洲裔美国人(AA)和 13,000 多名拉丁美洲人(LA)。分析这些样本的困难之一在于它们通常具有很强的混杂性,根据采集地区的不同,混杂模式也不同。PGC-PTSD 祖先工作组致力于开发新工具,以便将混血个体适当纳入 GWAS,并为 LMIC 合作者使用这些工具提供便利。在此之前,我们开发了 Tractor,这是一种针对混血人群的基因发现工具,它使用本地祖先推断(LAI)将这些个体纳入 GWAS 研究,并对其进行良好校准。目前,我们的主要工作之一是全面测试 LAI 的策略,为参数设置和参考面板组成提供指导。为此,我们考虑了不同的混杂模式(AA-2 方式和 LA-3 方式)、人口统计模型、软件设置、基因组数据类型和参考面板,对混杂个体进行了模拟。通过这些模拟,我们确定了最佳实践指南,供研究人员在分析不同人群时使用,以便在不同祖先间得出最高准确度的结果。在我们的测试中,我们发现美洲土著祖先区与欧洲和非洲祖先区相比,准确度明显降低。当误判发生时,LAI 误差率最常出现的方向是在真正的美洲土著地点判定欧洲人祖先,而不是其他误差模式。虽然我们的研究是直接针对实际的拉丁美洲混血人群组成的,但我们所描述的趋势对不同混血人群的当地祖先推断的最佳实践具有广泛的参考价值。在提高 LAI 分析准确性的同时,我们的工作小组还在为 Tractor 开发一个友好的管道,以便其他联盟可以将这种方法应用于大样本量。从未来的角度来看,PGC-PTSD 祖先工作组还将致力于开发用于后 GWAS 方法的新工具,如多基因评分。
{"title":"THE PGC-PSTD ANCESTRY WORKING GROUP: IMPROVING THE INCLUSION OF ADMIXED INDIVIDUALS IN PSYCHIATRIC GWAS","authors":"Marcos Santoro ,&nbsp;Jessica Mauer ,&nbsp;Adam Maihofer ,&nbsp;Nirav Shah ,&nbsp;Caroline Nievergelt ,&nbsp;Elizabeth Atkinson","doi":"10.1016/j.euroneuro.2024.08.016","DOIUrl":"10.1016/j.euroneuro.2024.08.016","url":null,"abstract":"<div><div>The latest PGC-PTSD GWAS achieved a considerable increase in the sample sizes of non-European populations, including more than 50,000 African American (AA) and 13,000 Latin American (LA) individuals. One of the difficulties in analyzing these samples is that they are usually very admixed, with different patterns of admixture according to the region they have been collected. The PGC-PTSD Ancestry working group is focused on developing new tools to allow proper inclusion of admixed individuals in GWAS and to facilitate the use of these tools for LMIC collaborators. Previously, we developed Tractor, a gene discovery tool for admixed populations that uses Local Ancestry Inference (LAI) to allow the well-calibrated inclusion of these individuals in GWAS studies. Currently, one of the primary efforts is to comprehensively test strategies for LAI to provide guidelines for parameter setting and reference panel composition. For this, we have simulated admixed individuals considering different patterns of admixture (AA-2 way and LA-3 way), demographic models, software settings, genomic data types, and reference panels. These simulations allow us to define best practice guidelines for researchers to use when analyzing diverse populations to produce the highest accuracy results across ancestries.</div><div>In our tests, we observe that Amerindigenous ancestry tracts suffer from notably reduced accuracy as compared to European and African tracts. When miscalls occur, LAI error rates are most frequently in the direction of calling European ancestry in true Amerindigenous sites than other error modes. Though our investigations are directly responsive to realistic admixed Latin American cohort compositions, the trends we characterize are broadly useful to inform best practice for local ancestry inference across diverse admixed populations. In parallel with this initiative of improving LAI analysis accuracy, our working group is developing a friendly pipeline for Tractor so other consortia can apply this approach for large sample sizes. As a future perspective, the PGC-PTSD ancestry working group will also work on the development of new tools for post GWAS approaches as polygenic scores.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Page 4"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EXPLORING THE IMMUNOGENETIC BASIS OF POST-TRAUMATIC STRESS DISORDER 探索创伤后应激障碍的免疫遗传基础
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.017
Alice Braun , Adam X Maihofer , Seyma Katrinli , Georgia Panagiotaropoulou , Daniel Levey , Stephan Ripke , Joel Gelernter , Caroline Nievergelt , PGC PTSD Working Group
<div><div>Post-Traumatic Stress Disorder (PTSD) is a complex psychiatric condition that develops following exposure to traumatic experiences. Its core symptoms include intrusive thoughts, avoidant behavior, and a persistent state of hyperarousal. Although it is widely recognized that stress exacerbates inflammation across tissues, a growing body of evidence suggests a reciprocal relationship, with immune function influencing susceptibility to PTSD. This relationship may be driven by shared underlying biology, such as from pleiotropy. The most recent genome-wide association study (GWAS) of PTSD identified 95 risk loci, including endocrine and immune regulators, such as the major histocompatibility complex (MHC). The MHC harbors numerous genetic variants such as human leukocyte antigen (HLA) alleles that are crucial for immune function. However, the complex linkage disequilibrium structure of the MHC poses challenges in isolating individual signals through SNP-based imputation. Here, we present a large-scale cross-ancestry analysis assessing the association of HLA alleles with PTSD.</div><div>We conducted HLA imputation and association analysis in a genotyped sample of individuals of African, European, or Latin American ancestry from 38 studies included in the latest PTSD GWAS published by the Psychiatric Genomics Consortium. The outcome phenotype was assessed as either case-control or on a continuous scale (e.g. the PTSD Checklist for DSM-IV or V). The 1000 Genomes Reference Panel, comprised of individuals from African, East Asian, European, South Asian, and American populations was employed to impute around 350 HLA alleles via SHAPEIT5 and MINIMAC4. Additionally, we introduced 21 long-range HLA haplotypes into the reference. Regression analyses were conducted using PLINK 2.0, while the first five principal components were included as covariates to adjust for population stratification. Finally, we employed METAL, using the sample-size weighting approach, to meta-analyze results from dichotomous and continuous outcomes.</div><div>We have generated preliminary results in a multi-ancestry sample (N = 60,159) that highlight HLA-DRB1*01:01 as the top risk-conferring allele across three ancestries (Z = 3.255, P = 1.14e-03). HLA-DRB1*01:01 was also the most significant HLA allele (Z = 2.380, P = 1.73e-02) in the Latin American sample (n = 7,072). In the African sample (n = 14,883), HLA-B*51:01 (Z = 3.553, P = 3.82e-04) emerged as the most significant HLA allele, while in Europeans (n = 38,204), the most significant allele HLA-B*08:01 showed a negative association with PTSD (Z = -2.555, P = 1.06e-02).</div><div>Our association analysis has identified multiple HLA alleles nominally associated with PTSD, with HLA-DRB1*01:01 emerging as the most significant possibly risk-conferring variant across ancestries. Notably, a protective effect of HLA-B*08:01 has previously been observed in schizophrenia and bipolar disorder. In the next steps, we will conduct imput
创伤后应激障碍(PTSD)是一种复杂的精神疾病,是在遭受创伤后出现的症状。其核心症状包括侵入性思维、回避行为和持续的过度焦虑状态。尽管人们普遍认为压力会加剧各组织的炎症反应,但越来越多的证据表明两者之间存在互为因果的关系,免疫功能会影响创伤后应激障碍的易感性。这种关系可能是由共同的潜在生物学因素驱动的,如多生物效应(pleiotropy)。创伤后应激障碍的最新全基因组关联研究(GWAS)确定了 95 个风险基因位点,包括内分泌和免疫调节剂,如主要组织相容性复合体(MHC)。主要组织相容性复合体(MHC)中存在大量遗传变异,如对免疫功能至关重要的人类白细胞抗原(HLA)等位基因。然而,MHC 复杂的连锁不平衡结构给通过基于 SNP 的估算分离个体信号带来了挑战。我们从精神疾病基因组学联盟(Psychiatric Genomics Consortium)最新发布的创伤后应激障碍 GWAS 中纳入的 38 项研究中,对非洲、欧洲或拉丁美洲血统的基因分型样本进行了 HLA 估算和关联分析。结果表型以病例对照或连续量表(如 DSM-IV 或 V 的创伤后应激障碍核对表)的形式进行评估。由非洲、东亚、欧洲、南亚和美洲人群组成的 1000 基因组参照组通过 SHAPEIT5 和 MINIMAC4 估算了约 350 个 HLA 等位基因。此外,我们还在参照中引入了 21 个长程 HLA 单倍型。使用 PLINK 2.0 进行回归分析,同时将前五个主成分作为协变量来调整人群分层。最后,我们采用了 METAL,使用样本量加权法对二分法和连续法的结果进行了元分析。我们在多血统样本(N = 60,159)中得出的初步结果显示,HLA-DRB1*01:01 是三个血统中风险最大的等位基因(Z = 3.255,P = 1.14e-03)。在拉丁美洲样本(n = 7 072)中,HLA-DRB1*01:01 也是最重要的 HLA 等位基因(Z = 2.380,P = 1.73e-02)。在非洲样本(n = 14883)中,HLA-B*51:01(Z = 3.553,P = 3.82e-04)是最重要的 HLA 等位基因,而在欧洲样本(n = 38204)中,最重要的等位基因 HLA-B*08:01 与创伤后应激障碍呈负相关(Z = -2.我们的关联分析发现了多个与创伤后应激障碍名义上相关的 HLA 等位基因,其中 HLA-DRB1*01:01 是不同血统中最重要的风险诱导变体。值得注意的是,以前曾在精神分裂症和躁狂症中观察到 HLA-B*08:01 的保护作用。下一步,我们将对位于 MHC III 类区的补体成分 4 进行估算和关联分析,并进行条件分析以确定其独立效应。最后,我们还将纳入更多大规模样本,如百万退伍军人计划和英国生物库,以提高统计能力。
{"title":"EXPLORING THE IMMUNOGENETIC BASIS OF POST-TRAUMATIC STRESS DISORDER","authors":"Alice Braun ,&nbsp;Adam X Maihofer ,&nbsp;Seyma Katrinli ,&nbsp;Georgia Panagiotaropoulou ,&nbsp;Daniel Levey ,&nbsp;Stephan Ripke ,&nbsp;Joel Gelernter ,&nbsp;Caroline Nievergelt ,&nbsp;PGC PTSD Working Group","doi":"10.1016/j.euroneuro.2024.08.017","DOIUrl":"10.1016/j.euroneuro.2024.08.017","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Post-Traumatic Stress Disorder (PTSD) is a complex psychiatric condition that develops following exposure to traumatic experiences. Its core symptoms include intrusive thoughts, avoidant behavior, and a persistent state of hyperarousal. Although it is widely recognized that stress exacerbates inflammation across tissues, a growing body of evidence suggests a reciprocal relationship, with immune function influencing susceptibility to PTSD. This relationship may be driven by shared underlying biology, such as from pleiotropy. The most recent genome-wide association study (GWAS) of PTSD identified 95 risk loci, including endocrine and immune regulators, such as the major histocompatibility complex (MHC). The MHC harbors numerous genetic variants such as human leukocyte antigen (HLA) alleles that are crucial for immune function. However, the complex linkage disequilibrium structure of the MHC poses challenges in isolating individual signals through SNP-based imputation. Here, we present a large-scale cross-ancestry analysis assessing the association of HLA alleles with PTSD.&lt;/div&gt;&lt;div&gt;We conducted HLA imputation and association analysis in a genotyped sample of individuals of African, European, or Latin American ancestry from 38 studies included in the latest PTSD GWAS published by the Psychiatric Genomics Consortium. The outcome phenotype was assessed as either case-control or on a continuous scale (e.g. the PTSD Checklist for DSM-IV or V). The 1000 Genomes Reference Panel, comprised of individuals from African, East Asian, European, South Asian, and American populations was employed to impute around 350 HLA alleles via SHAPEIT5 and MINIMAC4. Additionally, we introduced 21 long-range HLA haplotypes into the reference. Regression analyses were conducted using PLINK 2.0, while the first five principal components were included as covariates to adjust for population stratification. Finally, we employed METAL, using the sample-size weighting approach, to meta-analyze results from dichotomous and continuous outcomes.&lt;/div&gt;&lt;div&gt;We have generated preliminary results in a multi-ancestry sample (N = 60,159) that highlight HLA-DRB1*01:01 as the top risk-conferring allele across three ancestries (Z = 3.255, P = 1.14e-03). HLA-DRB1*01:01 was also the most significant HLA allele (Z = 2.380, P = 1.73e-02) in the Latin American sample (n = 7,072). In the African sample (n = 14,883), HLA-B*51:01 (Z = 3.553, P = 3.82e-04) emerged as the most significant HLA allele, while in Europeans (n = 38,204), the most significant allele HLA-B*08:01 showed a negative association with PTSD (Z = -2.555, P = 1.06e-02).&lt;/div&gt;&lt;div&gt;Our association analysis has identified multiple HLA alleles nominally associated with PTSD, with HLA-DRB1*01:01 emerging as the most significant possibly risk-conferring variant across ancestries. Notably, a protective effect of HLA-B*08:01 has previously been observed in schizophrenia and bipolar disorder. In the next steps, we will conduct imput","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 4-5"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COORDINATED EPISTASIS DETECTS HETEROGENOUS PATHWAYS ACROSS PSYCHIATRIC DISORDERS AND COMORBIDITIES 协调外显检测精神疾病和合并症的异质通路
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.077
Jolien Rietkerk , Morten Krebs , Lianyun Huang , Kajsa-Lotta Georgii Hellberg , IPSYCH Consortium , Thomas Werge , Andrew Schork , Andy Dahl , Na Cai
Cross-disorder analyses in psychiatry often center around genetic correlation, which quantifies the average similarity of genetic effects across two disorders. For a long time, this has been the only feasible approach, as most cohorts only collect data on a single disorder. However, few studies have examined the genetic architecture of comorbidity itself or how it relates to the genetic architecture of the individual disorders involved. In this study we set out to investigate the genetic architecture of comorbidity between psychiatric disorders in the iPSYCH2015 case-cohort study. This Danish register-based study contains comorbid cases for 10 pairs of five psychiatric disorders (schizophrenia (SCZ), bipolar disorder (BPD), major depressive disorder (MDD), autism (AUT) and attention deficit hyperactivity disorder (ADHD)), making it ideal for understanding comorbidity. We develop a novel framework to model both cross-disorder genetic sharing and the genetics of comorbidity based on the concept of Coordinated Epistasis (CE). Within this framework, we can identify synergistic and antagonistic interactions of Polygenic Risk Scores (PRS) across each disorder pair. We can also identify how these interactions impact individual disorders involved and delineate established theoretical models of comorbidity. In particular, we test one model of comorbidity where genetic effects distinguish comorbid cases from cases with only one disorder, which shows synergistic PRS interactions between ADHD-AUT comorbid cases and cases of either AUT or ADHD, which replicates in both iPSYCH2015 sub-cohorts: 2012 (P = 1.3E-02) and 2015i (P = 2.9E-02). We next apply our framework to family-based genetic scores (PA-FGRS), using recorded diagnoses from an average of 20 genetic relatives from the Danish medical registry. We find synergistic PA-FGRS interactions in comorbid ADHD-AUT (P = 1.1E-05), validating our PRS results. In summary, we perform the first comprehensive study on the genetics of comorbidity by extending the CE framework using a combination of PRS and PA-FGRS, and for the first time identify coordinated polygenic interactions contributing to cross-disorder genetic sharing and comorbidity among five psychiatric disorders.
精神病学的跨障碍分析通常以遗传相关性为中心,即量化两种障碍的遗传效应的平均相似性。长期以来,这是唯一可行的方法,因为大多数队列只收集单一疾病的数据。然而,很少有研究对合并症本身的遗传结构或其与所涉及的单个疾病的遗传结构之间的关系进行研究。在本研究中,我们着手调查 iPSYCH2015 病例队列研究中精神疾病合并症的遗传结构。这项基于丹麦登记册的研究包含五种精神疾病(精神分裂症(SCZ)、双相情感障碍(BPD)、重度抑郁障碍(MDD)、自闭症(AUT)和注意缺陷多动障碍(ADHD))中 10 对合并病例,因此非常适合了解合并症。我们根据协调外显(Coordinated Epistasis,CE)的概念,建立了一个新颖的框架,为跨障碍遗传共享和合并症遗传建模。在这一框架内,我们可以确定每对疾病的多基因风险评分(PRS)之间的协同和拮抗相互作用。我们还能确定这些相互作用如何影响所涉及的单个疾病,并划定已建立的合并症理论模型。特别是,我们测试了一种合并症模型,在该模型中,遗传效应将合并症病例与仅患有一种疾病的病例区分开来,该模型显示,ADHD-AUT 合并症病例与 AUT 或 ADHD 病例之间存在协同的 PRS 相互作用,这在 iPSYCH2015 两个子队列中都得到了复制:2012(P = 1.3E-02)和 2015i(P = 2.9E-02)。接下来,我们将我们的框架应用于基于家族的遗传评分(PA-FGRS),使用丹麦医疗登记册中平均 20 个遗传亲属的诊断记录。我们发现 PA-FGRS 在合并 ADHD-AUT 中具有协同作用(P = 1.1E-05),验证了我们的 PRS 结果。总之,我们通过结合使用 PRS 和 PA-FGRS 来扩展 CE 框架,首次对合并症的遗传学进行了全面研究,并首次确定了导致五种精神疾病的跨障碍遗传共享和合并症的协调多基因相互作用。
{"title":"COORDINATED EPISTASIS DETECTS HETEROGENOUS PATHWAYS ACROSS PSYCHIATRIC DISORDERS AND COMORBIDITIES","authors":"Jolien Rietkerk ,&nbsp;Morten Krebs ,&nbsp;Lianyun Huang ,&nbsp;Kajsa-Lotta Georgii Hellberg ,&nbsp;IPSYCH Consortium ,&nbsp;Thomas Werge ,&nbsp;Andrew Schork ,&nbsp;Andy Dahl ,&nbsp;Na Cai","doi":"10.1016/j.euroneuro.2024.08.077","DOIUrl":"10.1016/j.euroneuro.2024.08.077","url":null,"abstract":"<div><div>Cross-disorder analyses in psychiatry often center around genetic correlation, which quantifies the average similarity of genetic effects across two disorders. For a long time, this has been the only feasible approach, as most cohorts only collect data on a single disorder. However, few studies have examined the genetic architecture of comorbidity itself or how it relates to the genetic architecture of the individual disorders involved. In this study we set out to investigate the genetic architecture of comorbidity between psychiatric disorders in the iPSYCH2015 case-cohort study. This Danish register-based study contains comorbid cases for 10 pairs of five psychiatric disorders (schizophrenia (SCZ), bipolar disorder (BPD), major depressive disorder (MDD), autism (AUT) and attention deficit hyperactivity disorder (ADHD)), making it ideal for understanding comorbidity. We develop a novel framework to model both cross-disorder genetic sharing and the genetics of comorbidity based on the concept of Coordinated Epistasis (CE). Within this framework, we can identify synergistic and antagonistic interactions of Polygenic Risk Scores (PRS) across each disorder pair. We can also identify how these interactions impact individual disorders involved and delineate established theoretical models of comorbidity. In particular, we test one model of comorbidity where genetic effects distinguish comorbid cases from cases with only one disorder, which shows synergistic PRS interactions between ADHD-AUT comorbid cases and cases of either AUT or ADHD, which replicates in both iPSYCH2015 sub-cohorts: 2012 (P = 1.3E-02) and 2015i (P = 2.9E-02). We next apply our framework to family-based genetic scores (PA-FGRS), using recorded diagnoses from an average of 20 genetic relatives from the Danish medical registry. We find synergistic PA-FGRS interactions in comorbid ADHD-AUT (P = 1.1E-05), validating our PRS results. In summary, we perform the first comprehensive study on the genetics of comorbidity by extending the CE framework using a combination of PRS and PA-FGRS, and for the first time identify coordinated polygenic interactions contributing to cross-disorder genetic sharing and comorbidity among five psychiatric disorders.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 30-31"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SCIENCE COMMUNICATION: THE IMPORTANCE OF LANGUAGE IN A DIVERSE WORLD 科学传播:语言在多元化世界中的重要性
IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.euroneuro.2024.08.100
Helena Davies (Chair) , Abigail ter Kuile (Co-chair) , Helena Davies (Discussant)
Our aim as the PGC Outreach Committee is to improve visibility, accessibility, and understanding of psychiatric genetics amongst both the general public and the wider scientific community. But how accessible are we really? How easily interpreted is the information we share to non-scientists? And how can we improve?
A systematic review of media coverage and readability in genome-wide association studies, published earlier this year, concluded that the language used to describe genetics research is too complex to be understood by the public. Over 95% of the online news sites examined would require more than twelve years of formal education for a full understanding of their content. The importance of language, particularly in genetics research, can extend beyond ‘readability’ to even more fundamental issues. For instance, another recent systematic review emphasised the need for defining ancestry based on the type of data used for its measurement (e.g., “genetic ancestry”), as failure to do so can result in reduced clarity concerning the distinction between genetic and social identities.
This symposium will delve into the critical role of language in the effective communication of scientific concepts to diverse audiences. Our presenters will first each discuss what the importance of language in a diverse world means from their own unique perspective (10 minutes each). They will cover topics such as the importance of the choice of words in relation to genetic ancestry and other complex concepts in psychiatric genetics such as heritability, and the impact of language in discussions surrounding the lived experience of those with psychiatric disorders. Broadly, the presentations will highlight how we can bridge the gap between technical jargon and layman's terms, making complex ideas accessible to a broader audience including those living with psychiatric conditions and their families, as well as how we can more accurately use language in our communications within the scientific community.
We will then have a panel discussion (30 minutes) in which the presenters will share insights into, for example, some of the challenges they have faced in science communication, such as combating misinformation, and what they believe the consequences for our field will be if we do not carefully consider the role of accurate and responsible communication in psychiatric genetics. We will conclude the session with questions from the audience (15 minutes).
Ultimately, the symposium will demonstrate that effective science communication is a dynamic interplay of language, empathy, and engagement, and will encourage attendees to consider the impact of their words in shaping public perceptions and attitudes towards psychiatric genetics.
作为PGC外联委员会,我们的目标是提高精神遗传学在公众和广大科学界的知名度、可及性和理解度。但是,我们到底有多容易接近呢?我们分享给非科学家的信息有多容易解读?今年早些时候发表的一篇关于全基因组关联研究的媒体报道和可读性的系统综述得出结论:描述遗传学研究的语言过于复杂,公众难以理解。在接受审查的在线新闻网站中,超过 95% 的网站需要接受过 12 年以上的正规教育才能完全理解其内容。语言的重要性,尤其是在遗传学研究中的重要性,可能超出 "可读性 "的范畴,而涉及更根本的问题。例如,最近的另一篇系统综述强调了根据用于测量的数据类型(如 "遗传祖先")来定义祖先的必要性,因为如果不这样做,就会降低遗传身份与社会身份之间区别的清晰度。我们的发言人将首先从各自独特的角度讨论语言在多元化世界中的重要性(每人 10 分钟)。他们将讨论的话题包括:选择与遗传祖先和精神遗传学中其他复杂概念(如遗传率)相关的词语的重要性,以及语言在围绕精神疾病患者生活经历的讨论中的影响。从广义上讲,演讲将强调我们如何缩小专业术语与通俗用语之间的差距,让更多受众(包括精神疾病患者及其家人)了解复杂的概念,以及我们如何在科学界的交流中更准确地使用语言。然后,我们将进行小组讨论(30 分钟),发言人将分享他们在科学交流中遇到的一些挑战,例如如何与错误信息作斗争,以及如果我们不认真考虑准确和负责任的交流在精神病遗传学中的作用,他们认为会给我们的领域带来什么后果。最后,我们将以听众提问的形式结束本场会议(15 分钟)。本次研讨会将证明,有效的科学传播是语言、移情和参与的动态互动,并鼓励与会者考虑他们的言辞在塑造公众对精神遗传学的看法和态度方面所产生的影响。
{"title":"SCIENCE COMMUNICATION: THE IMPORTANCE OF LANGUAGE IN A DIVERSE WORLD","authors":"Helena Davies (Chair) ,&nbsp;Abigail ter Kuile (Co-chair) ,&nbsp;Helena Davies (Discussant)","doi":"10.1016/j.euroneuro.2024.08.100","DOIUrl":"10.1016/j.euroneuro.2024.08.100","url":null,"abstract":"<div><div>Our aim as the PGC Outreach Committee is to improve visibility, accessibility, and understanding of psychiatric genetics amongst both the general public and the wider scientific community. But how accessible are we really? How easily interpreted is the information we share to non-scientists? And how can we improve?</div><div>A systematic review of media coverage and readability in genome-wide association studies, published earlier this year, concluded that the language used to describe genetics research is too complex to be understood by the public. Over 95% of the online news sites examined would require more than twelve years of formal education for a full understanding of their content. The importance of language, particularly in genetics research, can extend beyond ‘readability’ to even more fundamental issues. For instance, another recent systematic review emphasised the need for defining ancestry based on the type of data used for its measurement (e.g., “genetic ancestry”), as failure to do so can result in reduced clarity concerning the distinction between genetic and social identities.</div><div>This symposium will delve into the critical role of language in the effective communication of scientific concepts to diverse audiences. Our presenters will first each discuss what the importance of language in a diverse world means from their own unique perspective (10 minutes each). They will cover topics such as the importance of the choice of words in relation to genetic ancestry and other complex concepts in psychiatric genetics such as heritability, and the impact of language in discussions surrounding the lived experience of those with psychiatric disorders. Broadly, the presentations will highlight how we can bridge the gap between technical jargon and layman's terms, making complex ideas accessible to a broader audience including those living with psychiatric conditions and their families, as well as how we can more accurately use language in our communications within the scientific community.</div><div>We will then have a panel discussion (30 minutes) in which the presenters will share insights into, for example, some of the challenges they have faced in science communication, such as combating misinformation, and what they believe the consequences for our field will be if we do not carefully consider the role of accurate and responsible communication in psychiatric genetics. We will conclude the session with questions from the audience (15 minutes).</div><div>Ultimately, the symposium will demonstrate that effective science communication is a dynamic interplay of language, empathy, and engagement, and will encourage attendees to consider the impact of their words in shaping public perceptions and attitudes towards psychiatric genetics.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 40-41"},"PeriodicalIF":6.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Neuropsychopharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1